Mohammad Effatpanah

1.2k total citations
76 papers, 765 citations indexed

About

Mohammad Effatpanah is a scholar working on Psychiatry and Mental health, Clinical Psychology and Epidemiology. According to data from OpenAlex, Mohammad Effatpanah has authored 76 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 19 papers in Clinical Psychology and 17 papers in Epidemiology. Recurrent topics in Mohammad Effatpanah's work include Attention Deficit Hyperactivity Disorder (13 papers), Substance Abuse Treatment and Outcomes (12 papers) and Mental Health Treatment and Access (8 papers). Mohammad Effatpanah is often cited by papers focused on Attention Deficit Hyperactivity Disorder (13 papers), Substance Abuse Treatment and Outcomes (12 papers) and Mental Health Treatment and Access (8 papers). Mohammad Effatpanah collaborates with scholars based in Iran, United States and Australia. Mohammad Effatpanah's co-authors include Shima Jazayeri, Rezvan Hashemi, Mahmoud Djalali, Mir Saeed Yekaninejad, Leila Khedmat, Ali Montazeri, Azadeh Tavoli, Zahra Tavoli, Ahmad Saedisomeolia and Agha Fatemeh Hosseini and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Psychiatry Research.

In The Last Decade

Mohammad Effatpanah

65 papers receiving 747 citations

Peers

Countries citing papers authored by Mohammad Effatpanah

Since Specialization

Citations

This map shows the geographic impact of Mohammad Effatpanah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Effatpanah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Effatpanah more than expected).

Fields of papers citing papers by Mohammad Effatpanah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Effatpanah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Effatpanah. The network helps show where Mohammad Effatpanah may publish in the future.

Co-authorship network of co-authors of Mohammad Effatpanah

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Effatpanah. A scholar is included among the top collaborators of Mohammad Effatpanah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Effatpanah. Mohammad Effatpanah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of Probiotics as Adjunctive Therapy to Fluoxetine on Depression Severity and Serum Brain‐Derived Neurotrophic Factor, Cortisol, and Adrenocorticotropic Hormone in Patients With Major Depressive Disorder: A Randomized, Double‐Blind, Placebo‐Controlled Trial 2025 ·Food Science & Nutrition ·(unknown), (unknown), Mehdi Tehrani‐Doost, Kianoush Khosravi‐Darani, (unknown), Mohammad Effatpanah, (unknown), (unknown), Shima Jazayeri	2
2	Uncovering antidepressant prescription patterns: a three-year analysis of outpatient trends 2025 ·BMC Psychiatry ·Hossein Karami, (unknown), Mohammad Effatpanah, (unknown), Rajabali Daroudi, (unknown), Leila Ghamkhar	0
3	Incidence, Prevalence, Mortality, and Direct Costs of Breast Cancer in Iran: Using the Iran Health Insurance Organization Database 2025 ·International Journal of Cancer Management ·Maryam Seyed-Nezhad, Mohammad Effatpanah, (unknown), Mohammad Esmaeil Akbari, (unknown), Mohammad Moradi-Joo	0
4	Medication use patterns and polypharmacy among elderly in Iran: a cross-sectional study using national health insurance claims data 2025 ·BMJ Open ·(unknown), Ali Golestani, Sepehr Khosravi, Ozra Tabatabaei‐Malazy, Mohammad‐Reza Malekpour, Mahbube Ebrahimpur, (unknown), (unknown), Mohammad Reza Amini, Mohammad Effatpanah	0
5	Overutilization of head computed tomography in cases of mild traumatic brain injury: a systematic review and meta-analysis 2024 ·Emergency Radiology ·(unknown), (unknown), Mohammad Effatpanah, (unknown), (unknown), Hossein Karami, (unknown), (unknown), Leila Ghamkhar	5
6	Antibiotic prescription prevalence in Iranian outpatients: A focus on defined daily doses and the AWaRe classification system 2024 ·American Journal of Infection Control ·Mohammad Nasehi, Mohammad Effatpanah, (unknown), Hossein Karami, (unknown), (unknown), (unknown), (unknown), Leila Ghamkhar	3
7	Burden and Epidemiology of Mental Disorders in the Middle East and North Africa from 1990 to 2019: Findings from the Global Burden of Disease Study 2024 ·Balkan Medical Journal ·Mohammad Effatpanah, Amin Nakhostin-Ansari, (unknown), (unknown), (unknown), (unknown), Amir Hossein Memari, (unknown)	14
8	Psychometric properties of Farsi version of Demoralization Scale-II (DS-II) in Iranian cancer patients 2024 ·Palliative & Supportive Care ·(unknown), (unknown), Roghieh Nooripour, David W. Kissane, Zahra Hooshyari, Mohammad Effatpanah, (unknown)	0
9	Changes in emergency department visits and mortality during the COVID-19 pandemic: a retrospective analysis of 956 hospitals 2024 ·Archives of Public Health ·(unknown), Mehdi Yaseri, Mohammad Effatpanah, Rajabali Daroudi	6
10	Comparing the Effectiveness of Internet-Based Cognitive Behavioral Therapy and Drug Therapy for Treating Postpartum Depression and Children Weight Gain: A Randomized Clinical Trial 2023 ·international journal high risk behaviors & addiction ·(unknown), Mohammad Effatpanah, (unknown), Mohammad Shariati, Azita Kheiltash, (unknown), (unknown)	2
11	Adherence to the MIND diet is inversely associated with odds and severity of anxiety disorders: a case–control study 2023 ·BMC Psychiatry ·(unknown), Hossein Shahinfar, Shima Jazayeri, Mohammad Effatpanah, Leila Azadbakht, Jamileh Abolghasemi	17
12	The predictive role of personality traits and demographic features on post-traumatic stress disorder in a sample of COVID-19 hospitalized patients 2023 ·Middle East Current Psychiatry ·(unknown), Mohammad Effatpanah, (unknown), ‬‬Samira Alesaeidi	1
13	National and Provincial Prevalence of Cigarette Smoking in Iran; A Systematic Analysis of 12 Years of STEPS Experience 2023 ·Archives of Iranian Medicine ·(unknown), (unknown), Esmaeil Mohammadi, Ali Ghanbari, Elaheh Shaker, Sina Azadnajafabad, Mohsen Abbasi‐Kangevari, Mohammad‐Mahdi Rashidi, Negar Rezaei, Sahar Mohammadi Fateh, (unknown), (unknown), Mohammad Effatpanah, Hamidreza Jamshidi, Farshad Farzadfar	2
14	Association between empirical dietary inflammatory index, odds, and severity of anxiety disorders: A case–control study 2023 ·Food Science & Nutrition ·(unknown), Hossein Shahinfar, Mohammad Effatpanah, Shima Jazayeri, Leila Azadbakht, Jamileh Abolghasemi, (unknown)	6
15	Effectiveness of Transcranial Direct Current Stimulation (tDCS) on Methamphetamine Craving 2020 ·(unknown), Mohammad Effatpanah, (unknown), Peyman Hassani‐Abharian	1
16	Effect of sweet almond syrup versus methylphenidate in children with ADHD: A randomized triple-blind clinical trial 2019 ·Complementary Therapies in Clinical Practice ·(unknown), Mohammad Effatpanah, Mehrdad Karimi, Shahin Akhondzadeh, (unknown), (unknown), Fatemeh Nejatbakhsh	13
17	Asymmetric dimethylarginine and soluble inter-cellular adhesion molecule-1 serum levels alteration following ginger supplementation in patients with type 2 diabetes: a randomized double-blind, placebo-controlled clinical trial 2018 ·Journal of Complementary and Integrative Medicine ·Meysam Zarezadeh, Ahmad Saedisomeolia, Masoud Khorshidi, (unknown), (unknown), (unknown), Mir Saeed Yekaninejad, Rezvan Hashemi, Mohammad Effatpanah, Niyaz Mohammadzadeh Honarvar	13
18	Vitamin D’s Molecular Action Mechanism in Attention-Deficit/ Hyperactivity Disorder: A Review of Evidence 2018 ·CNS & Neurological Disorders - Drug Targets ·Ahmad Saedisomeolia, (unknown), Fatemeh Gholami, (unknown), Mohammad Effatpanah, Rezvan Hashemi, Mina Abdolahi, (unknown)	13
19	The effect of an oral ginger supplementation on NF-κB concentration in peripheral blood mononuclear cells and anthropomorphic data of patients with type 2 diabetes: A randomized double-blind, placebo-controlled clinical trial 2018 ·Complementary Therapies in Medicine ·Niyaz Mohammadzadeh Honarvar, Meysam Zarezadeh, Masoud Khorshidi, (unknown), Mir Saeed Yekaninejad, (unknown), Mohammad Effatpanah, Rezvan Hashemi, Ahmad Saedisomeolia	16
20	Prevalence of Attention Deficit Hyperactivity Disorder in Pediatrics Patients Newly Diagnosed with Gastroesophageal Reflux Disease 2017 ·SHILAP Revista de lepidopterología ·Mohammad Effatpanah, Farzaneh Motamed, Mohammad Najafi, Fatemeh Farahmand, (unknown), (unknown), Mir Saeed Yekaninejad, Mostafa Qorbani, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact